ANTIBIOTIC PROPHYLAXIS IN LAPAROSCOPIC CHOLECISTECTOMY: IS IT WORTH DOING?

Márcio Alexandre Terra Passos1, Pedro Eder Portari-Filho2

  • 1University Hospital Severino Sombra, Vassouras, RJ, Brazil.

Insights

Routine antibiotic prophylaxis offers no significant benefit in preventing surgical site infections for low-risk patients undergoing elective laparoscopic cholecystectomy. This study found similar infection rates in both prophylaxis and no-prophylaxis groups.

Area of Science:

  • Surgical Infections
  • Antibiotic Prophylaxis
  • Minimally Invasive Surgery

Background:

  • Elective laparoscopic cholecystectomy carries a low risk of infectious complications, with reported rates between 0.4% and 1.1%.
  • Despite the low risk, many surgeons routinely administer antibiotic prophylaxis for this procedure.

Purpose of the Study:

  • To evaluate the actual impact of antibiotic prophylaxis on preventing infectious complications in low-risk patients undergoing elective laparoscopic cholecystectomy.

Main Methods:

  • A prospective, randomized, double-blind study was conducted with 100 patients.
  • Patients were divided into two groups: Group A (n=50) received intravenous Cefazolin prophylaxis, and Group B (n=50) received no antibiotic prophylaxis.
  • Surgical site infections were assessed at 7 and 30 days post-surgery.

Main Results:

  • The incidence of infectious complications was 2% in Group A and 2% in Group B.
  • No statistically significant difference in infectious complications was observed between the two groups (p=0.05).
  • The study groups were found to be homogeneous and comparable.

Conclusions:

  • Antibiotic prophylaxis does not provide a significant benefit in reducing surgical wound infections for patients undergoing elective laparoscopic cholecystectomy with low risk of complications.
Abstract